share_log

Piper Sandler Initiates Coverage On Cue Biopharma With Overweight Rating, Announces Price Target of $7

Piper Sandler Initiates Coverage On Cue Biopharma With Overweight Rating, Announces Price Target of $7

Piper Sandler以增持評級啟動對Cue Biophma的報道,宣佈目標價為7美元
Benzinga Real-time News ·  2022/11/21 05:08

Piper Sandler analyst Edward Tenthoff initiates coverage on Cue Biopharma (NASDAQ:CUE) with a Overweight rating and announces Price Target of $7.

Piper Sandler分析師Edward Tenthoff在Cue Biophma(納斯達克:CUE)上以增持評級發起報道,並宣佈目標價為7美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論